drugset / Trial / NCT02882191
Evaluation of the Efficacy and Safety of LevoCept
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the effectiveness, device placement, safety, and tolerability of LevoCept to support commencing a Phase III Clinical Study
Timeline
- Start
- 2016-11
- Primary completion
- 2018-07-17
- Completion
- 2020-11-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | — | Other |
Indications
No indication recorded.